Vetter Pharma

Among the world's most recognised contract development and manufacturing organisations for injectable drugs, Vetter Pharma has built its reputation on a single, demanding specialism: the aseptic fill-and-finish of parenteral drug products. Founded in 1950 and headquartered in Ravensburg, Germany, the privately held company has grown into a global partner for pharmaceutical and biotechnology innovators who require the highest standards of sterile manufacturing.

Vetter's core offering centres on aseptic filling into prefillable syringes, cartridges, and vials, making it a trusted partner across the full drug development lifecycle. Through its Vetter Development Service (VDS) division, the company supports clients from early clinical phases through to commercial-scale production, providing a seamless transition that reduces manufacturing risk and shortens time to market.

The company operates manufacturing and service facilities in Ravensburg and Langenargen in Germany, as well as a major facility in Skokie, Illinois, giving it a transatlantic manufacturing footprint suited to clients pursuing global regulatory approvals including those from the FDA and EMA. Its client base spans multinational pharmaceutical companies and emerging biotechnology firms, particularly those developing biologics, biosimilars, and combination products.

Vetter's long-standing focus on quality systems, cold-chain capability, and regulatory compliance has made it a recurring choice for complex, high-value drug products where contamination risk cannot be tolerated. The company remains family-influenced in its ownership and culture, a feature that clients frequently cite as contributing to its stability and long-term partnership approach.

Further information is available at vetter-pharma.com.